Hiew J, Lim Y, Liu H, Ng C
Commun Biol. 2025; 8(1):347.
PMID: 40025162
PMC: 11873215.
DOI: 10.1038/s42003-025-07790-w.
Hao Y, Li Z, Du X, Xie Q, Li D, Lei S
Mol Med. 2025; 31(1):82.
PMID: 40021952
PMC: 11871760.
DOI: 10.1186/s10020-025-01134-4.
Hossain M, Brahme R, Miller B, Amin J, de Barros M, Schneider J
Nat Commun. 2025; 16(1):1777.
PMID: 39971904
PMC: 11839910.
DOI: 10.1038/s41467-025-56985-6.
Guzman S, Brooks S
Free Radic Biol Med. 2025; 230:58-65.
PMID: 39892501
PMC: 11893230.
DOI: 10.1016/j.freeradbiomed.2025.01.053.
Tomar V, Sharma S, Siddhanta S, Deep S
Commun Chem. 2025; 8(1):22.
PMID: 39875596
PMC: 11775178.
DOI: 10.1038/s42004-025-01421-5.
Stem Cell Therapy for the Treatment of Amyotrophic Lateral Sclerosis: Comparison of the Efficacy of Mesenchymal Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells.
Frawley L, Taylor N, Sivills O, McPhillamy E, To T, Wu Y
Biomedicines. 2025; 13(1).
PMID: 39857620
PMC: 11763168.
DOI: 10.3390/biomedicines13010035.
Enhanced Interleukin 6 Trans-Signaling Modulates Disease Process in Amyotrophic Lateral Sclerosis Mouse Models.
Milligan C, Cowley D, Stewart W, Curry A, Forbes E, Rector B
Brain Sci. 2025; 15(1).
PMID: 39851451
PMC: 11764401.
DOI: 10.3390/brainsci15010084.
Tofersen and other antisense oligonucleotides in ALS.
Ludolph A, Wiesenfarth M
Ther Adv Neurol Disord. 2025; 18():17562864251313915.
PMID: 39845577
PMC: 11752197.
DOI: 10.1177/17562864251313915.
Artificial enforcement of the unfolded protein response reduces disease features in multiple preclinical models of ALS/FTD.
Valenzuela V, Becerra D, Astorga J, Fuentealba M, Diaz G, Bargsted L
Mol Ther. 2025; 33(3):1226-1245.
PMID: 39799393
PMC: 11897772.
DOI: 10.1016/j.ymthe.2025.01.004.
Gain-of-function ANXA11 mutation cause late-onset ALS with aberrant protein aggregation, neuroinflammation and autophagy impairment.
Liu Q, Sun Y, He B, Chen H, Wang L, Wang G
Acta Neuropathol Commun. 2025; 13(1):2.
PMID: 39755715
PMC: 11699697.
DOI: 10.1186/s40478-024-01919-4.
A dataset profiling the multiomic landscape of the prefrontal cortex in amyotrophic lateral sclerosis.
Hausmann F, Caldi Gomes L, Hanzelmann S, Khatri R, Oller S, Gebelin M
Gigascience. 2024; 13.
PMID: 39693632
PMC: 11653894.
DOI: 10.1093/gigascience/giae100.
The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis.
Tournezy J, Leger C, Klonjkowski B, Gonzalez-Dunia D, Szelechowski M, Garenne A
Int J Mol Sci. 2024; 25(23).
PMID: 39684507
PMC: 11641280.
DOI: 10.3390/ijms252312789.
ALDH3A1-mediated detoxification of reactive aldehydes contributes to distinct muscle responses to denervation and Amyotrophic Lateral Sclerosis progression.
Li A, Dong L, Li X, Yi J, Ma J, Zhou J
bioRxiv. 2024; .
PMID: 39677625
PMC: 11642873.
DOI: 10.1101/2024.12.02.626422.
Single-Nucleus RNA Sequencing Reveals the Spatiotemporal Dynamics of Disease-Associated Microglia in Amyotrophic Lateral Sclerosis.
Chen L, Zhang M, Xu H, Ye H, Chen D, Wang P
Research (Wash D C). 2024; 7:0548.
PMID: 39664295
PMC: 11632836.
DOI: 10.34133/research.0548.
Analysis of translatomic changes in the model of ALS reveals that motor neurons express muscle-associated genes in non-disease states.
Stansberry W, Fiur N, Robins M, Pierchala B
Front Neurol. 2024; 15:1491415.
PMID: 39628898
PMC: 11611750.
DOI: 10.3389/fneur.2024.1491415.
Divergent and Convergent TMEM106B Pathology in Murine Models of Neurodegeneration and Human Disease.
Du M, Akerman S, Fare C, Ruan L, Vidensky S, Mamedova L
Res Sq. 2024; .
PMID: 39606446
PMC: 11601866.
DOI: 10.21203/rs.3.rs-5306005/v1.
Intravenous administration of blood-brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system.
Wang C, Wang S, Xue Y, Zhong Y, Li H, Hou X
Nat Biotechnol. 2024; .
PMID: 39587229
DOI: 10.1038/s41587-024-02487-7.
Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and mice.
Hawley Z, Pardo I, Cao S, Zavodszky M, Casey F, Ferber K
Mol Ther. 2024; 33(1):215-234.
PMID: 39563026
PMC: 11764093.
DOI: 10.1016/j.ymthe.2024.11.029.
Recent Progress of Antisense Oligonucleotide Therapy for -Mutated Amyotrophic Lateral Sclerosis: Focus on Tofersen.
Moriyama H, Yokota T
Genes (Basel). 2024; 15(10).
PMID: 39457466
PMC: 11507444.
DOI: 10.3390/genes15101342.
Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron death.
Martinez P, Silva M, Abarzua S, Tevy M, Jaimovich E, Constantine-Paton M
Mol Med. 2024; 30(1):185.
PMID: 39455931
PMC: 11505737.
DOI: 10.1186/s10020-024-00942-4.